For Kodiak’s Macular Degeneration Antibody, Just as Good Isn’t Good Enough

Kodiak Sciences’ antibody designed to treat age-related macular degeneration with eye injections every three to five months was no better than Regeneron Pharmaceutical’s Eylea (aflibercept), the currently approved drug for the condition, injected every two months, Kodiak reported.
Source: Drug Industry Daily